Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.
O'Brien SM, Lamanna N, Kipps TJ, Flinn I, Zelenetz AD, Burger JA, Keating M, Mitra S, Holes L, Yu AS, Johnson DM, Miller LL, Kim Y, Dansey RD, Dubowy RL, Coutre SE. O'Brien SM, et al. Among authors: yu as. Blood. 2015 Dec 17;126(25):2686-94. doi: 10.1182/blood-2015-03-630947. Epub 2015 Oct 15. Blood. 2015. PMID: 26472751 Free PMC article. Clinical Trial.
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.
Flinn IW, Kahl BS, Leonard JP, Furman RR, Brown JR, Byrd JC, Wagner-Johnston ND, Coutre SE, Benson DM, Peterman S, Cho Y, Webb HK, Johnson DM, Yu AS, Ulrich RG, Godfrey WR, Miller LL, Spurgeon SE. Flinn IW, et al. Among authors: yu as. Blood. 2014 May 29;123(22):3406-13. doi: 10.1182/blood-2013-11-538546. Epub 2014 Mar 10. Blood. 2014. PMID: 24615776 Free PMC article. Clinical Trial.
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.
Brown JR, Byrd JC, Coutre SE, Benson DM, Flinn IW, Wagner-Johnston ND, Spurgeon SE, Kahl BS, Bello C, Webb HK, Johnson DM, Peterman S, Li D, Jahn TM, Lannutti BJ, Ulrich RG, Yu AS, Miller LL, Furman RR. Brown JR, et al. Among authors: yu as. Blood. 2014 May 29;123(22):3390-7. doi: 10.1182/blood-2013-11-535047. Epub 2014 Mar 10. Blood. 2014. PMID: 24615777 Free PMC article. Clinical Trial.
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.
Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ, Giese N, O'Brien S, Yu A, Miller LL, Lannutti BJ, Burger JA. Hoellenriegel J, et al. Blood. 2011 Sep 29;118(13):3603-12. doi: 10.1182/blood-2011-05-352492. Epub 2011 Jul 29. Blood. 2011. PMID: 21803855 Free PMC article. Clinical Trial.
A multi-institutional trial evaluating the use of an integrated quality assurance phantom for frameless single-isocenter multitarget stereotactic radiosurgery.
Capaldi DPI, Skinner LB, Pinkham DW, Zavgorodni S, Stafford O, Shirmohammad M, Matney JE, Dubrowski P, De Jean P, Grafil EM, Yu AS. Capaldi DPI, et al. Among authors: yu as. Front Oncol. 2024 Oct 31;14:1445166. doi: 10.3389/fonc.2024.1445166. eCollection 2024. Front Oncol. 2024. PMID: 39544300 Free PMC article.
Prospects for gene therapy in polycystic kidney disease.
Chakraborty A, Yu ASL. Chakraborty A, et al. Among authors: yu asl. Curr Opin Nephrol Hypertens. 2024 Oct 4. doi: 10.1097/MNH.0000000000001030. Online ahead of print. Curr Opin Nephrol Hypertens. 2024. PMID: 39499052
Treatment of Autosomal Dominant Polycystic Kidney Disease.
Jdiaa SS, Mustafa RA, Yu ASL. Jdiaa SS, et al. Among authors: yu asl. Am J Kidney Dis. 2024 Oct 16:S0272-6386(24)01032-1. doi: 10.1053/j.ajkd.2024.08.008. Online ahead of print. Am J Kidney Dis. 2024. PMID: 39424253 Free article. Review.
Dosimetric calibration of anatomy-specific ultra-high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments.
Wang J, Melemenidis S, Manjappa R, Viswanathan V, Ashraf RM, Levy K, Skinner LB, Soto LA, Chow S, Lau B, Ko RB, Graves EE, Yu AS, Bush KK, Surucu M, Rankin EB, Loo BW Jr, Schüler E, Maxim PG. Wang J, et al. Among authors: yu as. Med Phys. 2024 Sep 27. doi: 10.1002/mp.17432. Online ahead of print. Med Phys. 2024. PMID: 39331834
243 results